Answers are grounded in this paper and cite their sources.
Protein generative models design therapeutic backbones and sequences that are then filtered by cross-validation metrics. We review these methods, their therapeutic applications, and how far these metrics actually predict experimental success.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: